Bruno Mars Adds One More Show to His South Korea Tour… For a Total of 5 Shows in Goyang
Most of the 4 tickets available for advance booking have already been sold
Additional Performance Scheduled for May 29 Next Year in Response to Fan Support
First performance in Korea in four years since 2023
[Edaily Starin Reporter YUN GI BACK ] Pop star Bruno Mars is adding one more show to his concert tour in South Korea scheduled for next May. Since tickets for the original four shows sold out mostly during the pre-sale phase, the tour has been expanded to a total of five shows. Bruno Mars. According to Live Nation Korea on the 11th, Bruno Mars will take the stage at Goyang Sports Complex on May 29, in addition to the previously announced dates of May 21–22 and May 25–26. This brings the total number of shows for his first visit to Korea in about four years to five. The decision to add an extra show was made after most tickets for the original four shows sold out during the artist pre-sale and Live Nation pre-sale held on the 11th. Remaining tickets for the additional show on the 29th and the previously scheduled shows will go on sale at 12:00 PM on the 14th through the official ticketing site, NOL. Bruno Mars previously held two sold-out shows at the Jamsil Sports Complex Main Stadium in 2023. This time, he is moving the venue to the Goyang Sports Complex for five shows, once again demonstrating his strong ticket-selling power in Korea. This tour will center on “The Romantic,” Bruno Mars’ fourth solo studio album, released after a 10-year hiatus. His world tour, which began last April, has also seen sold-out shows and additional performances in major cities across North America and Europe. Anderson .Paak will join the show as a special guest under the name “DJ Piwi.” Anderson .Paak has previously collaborated with Bruno Mars as part of the duo Silk Sonic.
Chinese multilayer ceramic capacitor (MLCC) manufacturers are accelerating their entry into the global PC supply chain. They appear to be capitalizing on the supply gap in general-purpose MLCCs create…
SamilPharmaceutical(000520)With “Lorecivivint,” a new drug for osteoarthritis for which BioSplice holds exclusive domestic distribution rights, entering the regulatory review process in the UK followi…
Artificial intelligence (AI) translation and interpretation technology, which was previously used mainly in tourism and international conferences, is now making inroads into manufacturing and safety s…
